Effect of shear stress and a stable prostaglandin I2 analogue on adhesive interactions of colon cancer cells and endothelial cells

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 430-434

  Yoshida, Norimasa ^a   Yoshikawa, T ^a   Nakagawa, S ^a   Sakamoto, K ^a   Nakamura, Y ^a   Naito, Y ^a   Kondo, M ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adhesion molecules; Cancer metastasis; Endothelial cells; Prostaglandin I2; Shear stress

Indexed keywords

CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; PROSTACYCLIN DERIVATIVE;

ARTICLE; CELL ADHESION; CELL COUNT; CELL INTERACTION; COLON CANCER; COLON CARCINOGENESIS; ENDOTHELIUM CELL; ENZYME ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; MICROCIRCULATION; PRIORITY JOURNAL; SHEAR STRESS;

ADULT; CELL ADHESION; CELLS, CULTURED; COLONIC NEOPLASMS; E-SELECTIN; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; GANGLIOSIDES; HUMANS; INTERLEUKIN-1; PHYSICAL STIMULATION; TUMOR CELLS, CULTURED;

EID: 0032800431     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01017.x     Document Type: Article

References (23)

1. 1 Takada A, Ohmori K, Takahashi N et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, Sialyl Lewis a. Biochem Biophys Res Commun 1991; 179:713-6.
2. 2 Iwai K, Ishikura H, Kaji M et al. Importance or E-selectin (ELAM-1) and Sialyl Lewis a in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer 1993; 54:972-7.
3. 3 Takada A, Ohmori K, Yoneda T et al. Contribution of carbohydrate antigens Sialyl Lewis a and Sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993; 53:354-61.
4. 4 Sawada R, Tsuboi S, Fukuda M. Differential E-selectin-dependent adhesion efficiency in suhlines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1994; 269:1425-31.
5. 5 Lawrence MB, McIntire LV, Eskin SG. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood 1987; 70:1284-90.
6. 6 Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991; 87:1798-804.
7. 7 Yoshida N, Yoshikawa T, Nakamura Y et al. Interactions of neutrophils and endothelial cells under low flow conditions in vitro. Shock 1997; 8:125-30.
8. 8 Tozeren A, Kleinman HK, Grant DS et al. E-selectin-mediated dynamic interactions of breast-and colon-cancer cells with enduthelial-cell monolayers. Int J Cancer 1995; 60:426-31.
9. 9 Costantini V, Fuschiotti P, Giampietri A et al. Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice. Prostaglandins 1990; 39:581-99.
10. 10 Schirner M, Schneuder MR. Cicaprost inhibits metastases of animal tumors. Prostaglandins 1991; 42:451-61.
11. 11 Yoshida N, Granger DN, Anderson DC et al. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am J Physiol 1992; 262:111891-8.
12. 12 Toyota M, Hinoda Y, Itoh F et al. Complementary DNA cloning and characterization of truncated form of c-kit in human colon carcinoma cells. Cancer Res 1994; 54:272-5.
13. 13 Bevilacqua MP, Stengelin S, Gimbrone MAJ et al. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-5.
14. 14 Yoshida N, Takemura T, Granger DN et al. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells. Gastroenterology 1993; 105:715-24.
15. 15 Huang YW, Baluna R, Vitetta ES. Adhesion molecules as targets for cancer therapy. Histol Histopathol 1997; 12:467-77.
16. 16 Smith CW, Rothlein R, Hughes BJ et al. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 1988; 82:1746-56.
17. 17 Smith CW, Kishimoto TK, Abbassi O et al. Chemotactic factors regulate lectin adhesion molecule I (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulaled endothelial cells in vitro. J Clin Invest 1991; 87:609-18.
18. 18 Honn KV, Meyer J. Thromboxanes and prostacyelin: positive and negative modulators of tumor growth. Biochem Biophys Res Commun 1981; 102:1122-9.
19. 19 Menter DG, Onoda JM, Taylor JD et al. Effects of prostacyclin on tumor cell-induced platelet aggregation. Cancer Res 1984; 44:450-6.
20. 20 Honn KV, Tang DG, Grossi IM et al. A, Enhanced endothelial cell retraction mediated by 12(S)-HETE. A proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 1994; 210:1-9.
21. 21 Tang DG, Grossi IM, Tang KQ et al. Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyelin and its stable analogs: rationale for their antimetastatic effects. Int J Cancer 1995; 60:418-25.
22. 22 Safi F, Schlosser W, Falkenreck S et al. Prognostic value of CA19-9 serum course in pancreatic cancer. Hepatogastroenterology 1998; 45:253-9.
23. 23 Narimatsu H, Iwasaki H, Nakayama F et al. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res 1998; 58:512-8.